Lisa joined Alvogen in 2010 and serves as the CEO of Alvogen’s business.  She has worked in various leadership roles in the pharmaceutical industry for the past 20 years.  Her background in patent and regulatory strategy has been a key ingredient in Alvogen’s success.  Lisa’s own intellectual property strategy led to the company’s launch of the first generic Tamiflu following a successful compound patent challenge.  Under Lisa’s leadership, her team has launched a number of challenging first to market products, such as generic Exelon patch and generic Suboxone film.  As the generic market has transformed in recent years, Lisa’s commercial acumen and strategic insight have allowed Alvogen’s U.S. business to thrive.


Lisa holds her Juris Doctorate from Case Western University and an Honors Bachelor of Science degree from Lakehead University.

Lisa Graver

Tunie serves as the Chief Financial Officer.  She has 20 years of Finance experience, with over 10 years in the pharmaceutical industry. She was an integral part of the turnaround and growth of Par and its successful sale to Endo in 2015. 

Most recently, Tunie was the Generics Business Controller for Endo Pharmaceuticals where she was responsible for generics consolidated financial statements, global policy and processes, and alliance management. She has worked on several key organizational-wide strategic initiatives including leading the finance integration for Par and a number of restructuring initiatives resulting in bottom line savings. 

Tunie is a Certified Public Accountant in the state of New Jersey and holds a Bachelor’s degree in Accounting from Seton Hall University.

Tunie Zaku

Travis joined Alvogen in 2018 to lead the commercial business for our generics portfolio in the US Region.

He brings 20 years of experience from the pharmaceutical industry and has a proven track record of commercial leadership at companies including Bausch & Lomb, Cadista, URL/Mutual and Watson Pharmaceuticals.  At G&W Laboratories, he led the Sales and Marketing organization to successfully launch new products while maintaining strategic business in the constantly changing US market.

Travis holds a Bachelor’s degree in Business Administration from Brigham Young University in Provo, Utah and a MBA in Finance and Marketing from the University of South Florida in Tampa.

Travis Roberts

As Human Resources Director, Emily is responsible for all strategic initiatives related to employee development, engagement and retention in the US region. Her role includes supporting staff growth by developing and implementing comprehensive reward, training and leadership programs; recruiting and onboarding new employees to the company; and ensuring adherence to government and legal requirements.

Emily is an accomplished Human Resources professional with extensive experience in the pharmaceutical, consumer goods, and manufacturing industries. Prior to Alvogen, Emily held progressive roles at Novartis, Gerber Products, Viacom and Occidental Chemical. Emily holds a Bachelor’s Degree in Communications from Northwestern University.

Emily Smith

As Vice President of Information Technology for the US Region, Neha’s roles include supporting Alvogen’s growth by partnering with the company's business units to fuel innovation and provide strategic insights through the use of cutting-edge technology. Through her efforts, Neha brings daily IT efficiency to all staff.

Neha joined Alvogen in 2015 and has more than 20 years of extensive Information Technology experience in the pharmaceutical, telecommunication and banking industries.  Prior to joining Alvogen, she ensured superior IT processes at Daiichi Sankyo Pharma.  Neha holds a Bachelor’s of Science degree from the New Jersey Institute of Technology.

Neha Patel

As head of Legal for the US, Andrea directs legal strategy for the US business and provides legal guidance to all departments. She leads Alvogen’s Hatch Waxman litigation strategy and also handles US transactions including acquisitions and partnerships.  Prior to joining Alvogen, Andrea served as Director, Intellectual Property at Actavis.  

She also worked as an Intellectual Property attorney at a boutique law firm.  She received her JD, cum laude, from Western New England University, Bachelors of Arts degrees, cum laude, in Biochemistry/Molecular Biology and Psychology from Boston University and her MBA, with honors, from University of Massachusetts, Amherst.  Andrea has licenses to practice law in New York, New Jersey and Connecticut and is also a registered US Patent Attorney.

Andrea Sweet

Andrea Johnson has more than 20 years of experience in both generic and branded pharmaceuticals. Her knowledge and experience in customer focus, operational effectiveness, teambuilding and process improvements (Kaizen and Lean Six Sigma) allows her to effectively lead and manage Alvogen’s Customer Service, Credit & Collections and Contracting & Pricing operations.

Prior to joining Alvogen, Mrs. Johnson Andrea was the Senior Director of Pricing & Contracts and Financial Sales Operations at Activis Inc., where she was able to successfully led significant operational improvements resulting in millions of dollars in savings.

Mrs. Johnson Andrea has held roles of increasing responsibility throughout her career including successful positions at Johnson & Johnson Healthcare Systems, Pfizer and Alpharma. She has advanced degrees in Education and Mathematics.

Andrea Johnson

Richard joined Alvogen in February 2017, to lead Alvogen’s Sales, Marketing, and Commercial Operations for the US Injectables business unit.    

He brings a wealth of brand and generic injectable pharmaceutical experience spanning more than thirty years.  Most recently, Richard served as VP Sales and Marketing at startup, Claris Lifesciences, helping establish and grow their US business.  Prior to Claris, Richard held positions of increasing responsibility as Director of Sales and Marketing at American Regent.  He has extensive experience in sales and sales management, national accounts, and trade relations, and served in roles with Bedford Labs, Ivax, Squibb Diagnostics, and LyphoMed.

Richard holds a Bachelor’s Degree in Business Management from Marshall University.

Richard Harker

Rama joined Alvogen in September 2018 and is responsible for all aspects of Generics and Brand R&D, including Biopharmaceutics, Clinical Pharmacology, Project Management,product transfers and commercial validation at all internal and external sites.  

Rama is a seasoned executive with over twenty years in the pharmaceutical industry, with significant development experience in complex generics and 505(b)2 products. Most recently he was the Vice President and Generic R&D Site Head for the Teva Pharmaceuticals Elizabeth, New Jersey site.  There he managed a R&D team involved in the development of complex generic products including first to file and first to market as well as some brand products for US market. Rama also oversaw the development of generic products for European, Mexican and Canadian markets. 

Rama holds a BS in Pharmaceutical Sciences, and a MS in Pharmaceutics and  Ph.D. in Pharmaceutics all from Andhra University in India.  He also has post-doctoral research experience at Kyoto Pharmaceutical University in Kyoto, Japan.  In addition, he is the recipient of numerous awards for his work, as well as a published author for scientific research articles.

Rama Yarasani

Alvogen’s leadership team is dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and thus enabling the company to bring new generic products quickly and safely to market. The executive leadership team forms the Alvogen Management Board.

Meet our management